Krishna Vaddi - Dec 20, 2022 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)

Role: CEO, Director
Signature: /s/ Krishna Vaddi
Stock symbol: PRLD
Transactions as of: Dec 20, 2022
Transactions value $: $98,446
Form type: 4
Date filed: 12/21/2022, 03:08 PM
Previous filing: Feb 17, 2022
Next filing: Feb 9, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRLD	Common Stock	Purchase	$98.4K	+19.2K	+18.91%	$5.13	121K	Dec 20, 2022	See Footnote	F1, F2
holding	PRLD	Common Stock						1.05M	Dec 20, 2022	Direct	F3
holding	PRLD	Common Stock						552K	Dec 20, 2022	By Trust	F4
holding	PRLD	Common Stock						552K	Dec 20, 2022	By Trust	F5
holding	PRLD	Common Stock						424K	Dec 20, 2022	By Trust	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.03 to $5.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
F2	The Reporting Person is the manager of Sidus Ventures LLC. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
F3	Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met.
F4	The Reporting Person is the investment advisor of the Blue Sky Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
F5	The Reporting Person is the investment advisor of the Brocade Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
F6	The Reporting Person is a beneficiary of the Dolphin City Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.